Skip to main content

Animations

MJFF Publications

5521 - 5530 of 8808 Results
Title
Year
  • Year
  • 2020
  • 2018
  • 2022
  • 2017
  • 2024
  • 2021
  • 2017
  • 2019
  • 2024
  • 2019
  • Summary Details
    OPEN
    Title: 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa276
    Citation Count: 144
  • Summary Details
    OPEN
    Title: Parkin targets NOD2 to regulate astrocyte endoplasmic reticulum stress and inflammation
    Journal Name: Glia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/glia.23482
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?
    Journal Name: Frontiers in Human Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnhum.2022.809905
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Mitostasis in Neurons: Maintaining Mitochondria in an Extended Cellular Architecture
    Journal Name: Neuron
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuron.2017.09.055
    Citation Count: 503
  • Summary Details
    OPEN
    Title: Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders
    Journal Name: Bioengineering & Translational Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/btm2.10665
    Citation Count: 2
  • Summary Details
    RESTRICTED
    Title: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28630
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1616874114
    Citation Count: 79
  • Summary Details
    RESTRICTED
    Title: Reply to letter to the editor “Adaptive DBS in Parkinson's disease: Headlines, perspectives and challenges”
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2019.06.014
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s0140-6736(24)00476-8
    Citation Count: 401
  • Summary Details
    OPEN
    Title: ARSA variants in α-synucleinopathies
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awz340
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.